| 0 (0%) | 10-15 12:19 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 81.01 | 1-year : | 84.68 |
| Resists | First : | 69.36 | Second : | 72.5 |
| Pivot price | 66.12 |
|||
| Supports | First : | 64.29 | Second : | 53.48 |
| MAs | MA(5) : | 66.6 |
MA(20) : | 66.56  |
| MA(100) : | 73.22 |
MA(250) : | 82.41 |
|
| MACD | MACD : | -1.2 |
Signal : | -1.5 |
| %K %D | K(14,3) : | 71.1 |
D(3) : | 60.7 |
| RSI | RSI(14): 41.7 |
|||
| 52-week | High : | 110.66 | Low : | 64.29 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CNS ] has closed below upper band by 29.4%. Bollinger Bands are 57.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 67.77 - 68.04 | 68.04 - 68.3 |
| Low: | 65.28 - 65.58 | 65.58 - 65.87 |
| Close: | 66.56 - 67.03 | 67.03 - 67.48 |
Wed, 15 Oct 2025
Bexorg Raises $42.5 Million Led by Engine Ventures to Advance AI and Whole-Human Brain Platform for CNS Drug Discovery - citybiz
Wed, 15 Oct 2025
Metastatic Brain Tumor Collaborative Announces First-Ever Collaborative Grant Opportunity Focused on CNS Metastasis - Newswise
Wed, 15 Oct 2025
Cohen & Steers Inc (CNS) Q3 2025 Earnings Report Preview: What T - GuruFocus
Wed, 15 Oct 2025
Dynamic modulation of the blood–brain barrier in the healthy brain - Nature
Wed, 15 Oct 2025
Muna Therapeutics ahead of new funding round: "A conference like this is an opportunity" - medwatch.com
Wed, 15 Oct 2025
How Growing Spotlight on High Yield Funds at Cohen & Steers (CNS) Is Shaping Income Strategies - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 51 (M) |
| Shares Float | 28 (M) |
| Held by Insiders | 46 (%) |
| Held by Institutions | 60.2 (%) |
| Shares Short | 2,050 (K) |
| Shares Short P.Month | 1,980 (K) |
| EPS | 3.15 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 10.35 |
| Profit Margin | 29.8 % |
| Operating Margin | 31.8 % |
| Return on Assets (ttm) | 14.8 % |
| Return on Equity (ttm) | 32.5 % |
| Qtrly Rev. Growth | 11.8 % |
| Gross Profit (p.s.) | 5.06 |
| Sales Per Share | 10.65 |
| EBITDA (p.s.) | 3.8 |
| Qtrly Earnings Growth | 14.3 % |
| Operating Cash Flow | -116 (M) |
| Levered Free Cash Flow | 171 (M) |
| PE Ratio | 21.15 |
| PEG Ratio | 0 |
| Price to Book value | 6.43 |
| Price to Sales | 6.25 |
| Price to Cash Flow | -29.28 |
| Dividend | 0.62 |
| Forward Dividend | 0 |
| Dividend Yield | 0.9% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|